The Respiratory Effectiveness Group (REG) is a not-for-profit initiative established by international experts in real-life and comparative effectiveness research in respiratory medicine. The Group sets quality standards in the field of real-life research and improves understanding of the optimum role of real-life data to inform meaningful clinical practice guidelines, drug licensing and post-marketing surveillance processes and improved patient care.